Allergan to pay $2.7m to settle antitrust suit over Asacol
06-08-2019
Photo: TATSIANAMA / Shutterstock.com
Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Actavis, Zydus, patent dispute, generic drugs, Asacol, FDA, ANDA
